Ignite Creation Date:
2024-05-05 @ 7:02 PM
Last Modification Date:
2024-10-26 @ 9:42 AM
Study NCT ID:
NCT00597389
Status:
COMPLETED
Last Update Posted:
2008-01-18
First Post:
2008-01-09
Brief Title:
Propranolol Administration and Prevention of Child PTSD in Child Trauma Victims
Sponsor:
Kent State University
Organization:
Kent State University
Study Overview
Official Title:
The Efficacy of Early Propranolol Administration at PreventingReducing PTSD Symptoms in Child Trauma Victims Pilot
Status:
COMPLETED
Status Verified Date:
2008-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Twenty-nine pediatric injury patients ages 10-18 at risk for PTSD were randomly assigned to receive either propranolol or placebo in a double-blind placebo controlled design Medication was initiated within 12 hours of hospital admission At 6-weeks child PTSD symptoms and heart rate HR during trauma recall were assessed We hypothesized that participants who received propranolol would report fewer PTSD symptoms and have lower heart rates than those who received placebo
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None